K. Felgenhauer

M. Mäder, K. Felgenhauer, U. Dickmann, 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Elektrophorese von Serum und Liquor cerebrospinalis in Polyacrylamid-Gel

K. Felgenhauer, S. Bach, A. Stammler, 1967, Klinische Wochenschrift.

Hochmolekulares γG-Paraprotein im Liquor cerebrospinalis bei Plasmocytom

K. Felgenhauer, P. G. Scheurlen, A. Pappas, 1967, Klinische Wochenschrift.

Monoclonal immunoglobulins on disc electrophoresis

K. Felgenhauer, G. Alzer, K. Schumacher, 1972, Klinische Wochenschrift.

Immunoglobulins in disc electrophoresis.

K. Felgenhauer, 1972, Clinica chimica acta; international journal of clinical chemistry.

Periodic acid-Schiff staining of unsaturated serum lipoproteins following disc electrophoresis.

K. Felgenhauer, B. Huismans, 1971, Biochimica et biophysica acta.

Quantitation and specific detection methods after disc electrophoresis of serum proteins.

K. Felgenhauer, 1970, Clinica chimica acta; international journal of clinical chemistry.

Evaluation of Molecular Radius by Exclusion Gel Electrophoresis, Demonstrated on Haptoglobins*

K. Felgenhauer, 1970 .

Microelectrophoresis on polyacrylamide gel.

K. Felgenhauer, 1967, Biochimica et biophysica acta.

A novel enzyme-linked immunosorbent assay for determination of synaptophysin as compared with other quantification procedures

R. Poethke, K. Felgenhauer, G. Schlaf, 1996, Journal of Neuroimmunology.

Human intestinal alkaline phosphatase‐binding IgG in patients with severe bacterial infections

W. Beuche, M. Mäder, K. Felgenhauer, 1994, Clinical and experimental immunology.

Antibodies Raised Against Synthetic Peptides React with Choline Acetyltransferase in Various Immunoassays and in Immunohistochemistry

J. Unger, B. Schmidt, K. Felgenhauer, 1993, Journal of neurochemistry.

Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid.

V. Armstrong, H. Reiber, K. Felgenhauer, 1991, Clinica chimica acta; international journal of clinical chemistry.

Two-dimensional separation of human body fluid proteins.

K. Felgenhauer, D. Hagedorn, 1980, Clinica chimica acta; international journal of clinical chemistry.

Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: An indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier

P. Rieckmann, J. Wiltfang, K. Felgenhauer, 1993, Journal of Neuroimmunology.

Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction.

W. Lüke, B. Ruf, H. Pohle, 1994, The Journal of infectious diseases.

Neuropathy and monoclonal IgM M-protein with antibody activity against gangliosides

A. Steck, M. Schluep, K. Felgenhauer, 1987, Journal of Neuroimmunology.

Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis

P. Rieckmann, K. Felgenhauer, B. Kallmann, 1998, Multiple sclerosis.

diagnosis of Creutzfeldt-Jakob disease

B. Steinhoff, B. Mollenhauer, I. Zerr, 1998 .

Specificity of intrathecal IgG synthesis for HTLV‐1 core and envelope proteins in HAM/TSP

P. Rieckmann, W. Bodemer, K. Felgenhauer, 1995, Acta neurologica Scandinavica.

The proliferation rate of T and B lymphocytes in cerebrospinal fluid

R. S. Thomas, W. Beuche, K. Felgenhauer, 1991, Journal of Neurology.

The process dynamics of viral and bacterial diseases of the central nervous system

K. Felgenhauer, R. Ackermann, G. Schliep, 1980, Journal of the Neurological Sciences.

Large-scale purification of synaptophysin and quantification with a newly established enzyme-linked immunosorbent assay.

M. Mäder, K. Felgenhauer, G. Schlaf, 1996, Biological chemistry.

The detection of activated cerebrospinal fluid B lymphocytes by peroxidase conjugated antibodies

K. Felgenhauer, H. Schädlich, M. Nekic, 2004, Journal of Neurology.

OKT8-binding lymphocytes in diseases of the nervous system

K. Felgenhauer, H. Schädlich, Y. Bliersbach, 1983, Journal of Neuroimmunology.

Soluble adhesion molecules (sVCAM‐1 and sICAM‐1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis

J. Baudewig, P. Rieckmann, K. Felgenhauer, 1997, Annals of neurology.

The Filtration Concept of the Blood-CSF-Barrier as Basis for the Differentiation of CSF Proteins

K. Felgenhauer, 1995 .

Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system.

H. Reiber, K. Felgenhauer, 1987, Clinica chimica acta; international journal of clinical chemistry.

Injury: State of the Art Report

T. Sears, B. Fields, V. Meulen, 1982 .

Toward an improved immunoglobulin analysis by gel electrophoresis and electrofocusing

A. Chrambach, K. Felgenhauer, Birgit An der Lan, 1981 .

Class differentiation of immunoglobulin-containing cerebrospinal fluid cells in inflammatory diseases of the central nervous system

P. Rieckmann, K. Felgenhauer, T. Weber, 1990, Klinische Wochenschrift.

Diagnostic significance of IgG-synthesizing activated B cells in acute inflammatory diseases of the central nervous system

K. Felgenhauer, H. Schädlich, 1985, Klinische Wochenschrift.

Acute diffuse leukoencephalitis in HIV-1 infection.

S. Poser, W. Lüer, K. Felgenhauer, 1994, Journal of neurology, neurosurgery, and psychiatry.

Cerebrospinal fluid virus antibodies A diagnostic indicator for multiple sclerosis?

R. Ackermann, K. Felgenhauer, H. Schädlich, 1985, Journal of the Neurological Sciences.

Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system

K. Felgenhauer, G. Schliep, N. Rapic, 1976, Journal of the Neurological Sciences.

Chronic HIV encephalitis — I. cerebrospinal fluid diagnosis

S. Poser, H. Pohle, W. Lüer, 1988, Klinische Wochenschrift.

Chronic HIV encephalitis

S. Poser, W. Lüer, K. Felgenhauer, 1988, Journal of Neuroimmunology.

β Trace-protein as marker for cerebrospinal fluid fistula

K. Felgenhauer, H. Schädlich, M. Nekic, 1987, Klinische Wochenschrift.

Serum-CSF protein gradients, the blood-CSF barrier and the local immune response

K. Felgenhauer, G. Schliep, 1978, Journal of Neurology.

Origin and Immunoregulation of Autoantibodies Against Intestinal Alkaline Phosphatase

W. Beuche, K. Felgenhauer, N. Kolbus, 1995, Scandinavian journal of immunology.

Detection of T cells reactive to intestinal alkaline phosphatase, an autoantigen in acute bacterial infections, and discrimination between autoantigen‐specific CD5+ and CD5− B cells

W. Beuche, K. Felgenhauer, N. Kolbus, 1997, Clinical and experimental immunology.

Molecular size of human serum proteins determined by exclusion gel electrophoresis.

K. Felgenhauer, 1971, Clinica chimica acta; international journal of clinical chemistry.

Synthetic ampholytes for the isoelectric focusing of proteins.

S. Vinogradov, K. Felgenhauer, S. Pak, 1973, Biochemical and biophysical research communications.

Third International Congress of Histochemistry and Cytochemistry: August 18–22, 1968, New York, N.Y.

W. D. Selles, W. W. Doane, J. E. Kephart, 1968 .

Third International Congress of Histochemistry and Cytochemistry

Richard E. Cornell, W. D. Selles, W. W. Doane, 1968 .

The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system

H. Reiber, K. Felgenhauer, Prof. Dr. K. Felgenhauer, 2004, The clinical investigator.

Fine specificities of antibodies in sera and cerebrospinal fluid in herpes virus infections of the central nervous system as detected by the antigen variable immunoblot technique

K. Felgenhauer, K. Ritter, B. Neumann, 1990, Journal of Neuroimmunology.

Differentiation of the humoral immune response in inflammatory diseases of the central nervous system

K. Felgenhauer, Felgenhauer Neurologisch-psychiatrische Forschungsabteilung, Universit its-Nervenklinik, 2004, Journal of Neurology.

Apurulent bacterial meningitis (compartmental leucopenia in purulent meningitis)

K. Felgenhauer, D. Kober, 2004, Journal of Neurology.

Migration of human granulocytes through reconstituted basement membrane is not dependent on matrix metalloproteinase-9 (MMP-9)

F. Weber, R. Hardeland, W. Beuche, 2001, Journal of Neuroimmunology.

The demonstration of locally synthesized herpes simplex IgG antibodies in CSF by a Sepharose 4B linked enzyme immunoassay

K. Felgenhauer, R. Ackermann, M. Nekic, 1982, Journal of Neuroimmunology.

Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells

W. Brück, P. Rieckmann, U. Michel, 1995, Journal of Neuroimmunology.

Serum-CSF protein gradients, the blood-CSF barrier and the local immune response

K. Felgenhauer, G. Schliep, 1978, Journal of Neurology.

Serum-CSF protein gradients, the blood-CSF barrier and the local immune response

K. Felgenhauer, G. Schliep, 1978, Journal of Neurology.

Late elevation of CSF proteins in three cases of mumps meningoencephalitis

K. Felgenhauer, A. Statz, 1982, Brain and Development.

Local Protein Synthesis and Passive Transfer in Human Body Fluid Formation

K. Felgenhauer, 1985 .

Characterization of Monoclonal and Polyclonal Antibodies to Human Choline Acetyltransferase and Epitope Analysis

W. Härtig, G. Brückner, R. Poethke, 1997, Biological chemistry.

An efficient sandwich-ELISA for the determination of choline acetyltransferase.

M. Mäder, K. Felgenhauer, C. Ostermann-Latif, 1993, Journal of immunological methods.

The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid

H. Reiber, C. Jacobi, K. Felgenhauer, 1986, Journal of Neurology.

Sensitive quantitation of carcinoembryonic antigen in cerebrospinal fluid and its barrier-dependent differentiation.

H. Reiber, C. Jacobi, K. Felgenhauer, 1986, Clinica chimica acta; international journal of clinical chemistry.

Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase

S. Dimauro, R. Friede, H. Goebel, 1987, Acta Neuropathologica.

The α2-macroglobulin level in cerebrospinal fluid; a parameter for the condition of the blood-CSF barrier

K. Felgenhauer, G. Schliep, 2004, Journal of Neurology.

Acute demyelinating disease. Classification and non‐invasive diagnosis

J. Frahm, H. Bruhn, S. Poser, 1992, Acta neurologica Scandinavica.

Carrier ampholyte distribution in isoelectric focusing

S. Vinogradov, K. Felgenhauer, Ray K. Brown, 1977 .

Psychiatric disorders in the encephalitic form of multiple sclerosis

K. Felgenhauer, 1990, Journal of Neurology.

The compartmental IgM and IgA response within the central nervous system

K. Felgenhauer, H. Schädlich, 1987, Journal of the Neurological Sciences.

β‐Trace protein in cerebrospinal fluid: A blood–CSF barrier–related evaluation in neurological diseases

R. Nau, K. Felgenhauer, Hayrettin Tumanin, 1998, Annals of neurology.

Beta-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitis

R. Nau, H. Reiber, H. Tumani, 1998, Neuroscience Letters.

Choroid plexus: the major site of mRNA expression for the β-trace protein (prostaglandin D synthase) in human brain

W. Brück, Y. Urade, O. Hayaishi, 1996, Neuroscience Letters.

[On the esterolytic effect of Toxogonin].

K. Felgenhauer, R. Heitmann, 1969, Deutsche medizinische Wochenschrift.

How to improve the clinical diagnosis of Creutzfeldt-Jakob disease.

B. Steinhoff, B. Mollenhauer, W. Schulz-Schaeffer, 1999, Brain : a journal of neurology.

Development of the Blood‐CSF Barrier

K. Felgenhauer, A. Statz, 1983, Developmental medicine and child neurology.

Differentiation of the humoral immune response in herpes simplex encephalitis

K. Felgenhauer, H. Schädlich, M. Nekic, 1990, Journal of Neuroimmunology.

Rapid Determination of Proteins in Serum and Cerebrospinal Fluid by Laser-Nephelometry

K. Felgenhauer, G. Schliep, 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

The Development of the Blood-CSF Barrier after Birth

K. Felgenhauer, D. Wenzel, 1976, Neuropadiatrie.

Quantitation of High-Molecular Proteins in Cerebrospinal Fluid

K. Felgenhauer, G. Schliep, N. Rapic, 1974, Zeitschrift fur klinische Chemie und klinische Biochemie.

Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy

B. Steinhoff, W. Paulus, H. Bittermann, 1999, Epilepsy Research.

CNS barriers and modern CSF diagnostics

M. Holzgraefe, K. Felgenhauer, H. Prange, 1993 .

Specific antigen binding by activated cerebrospinal fluid B lymphocytes in acute neuroborreliosis

W. Beuche, K. Felgenhauer, A. Siever, 1992, Journal of Neurology.

Transmission of Creutzfeldt-Jakob disease by handling of dura mater

M. Palmer, J. Collinge, H. Tumani, 1993, The Lancet.

Neuropathy and Monoclonal IgM M‐Protein with Antibody Activity Against Gangliosides

A. Steck, K. Felgenhauer, F. Jerusalem, 1988 .

Serum levels of macrophage-derived protein MRP-8/14 are elevated in active multiple sclerosis

W. Brück, P. Rieckmann, K. Felgenhauer, 1998, Neuroscience Letters.

Immunological techniques following microelectrophoresis on polyacrylamide gel.

K. Felgenhauer, 1968, Biochimica et biophysica acta.

Barrier concepts and CSF analysis.

K. Felgenhauer, 1992, Journal of neurology.

Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system

U. Michel, K. Felgenhauer, L. Wöckel, 1995, Neuroscience Letters.

Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV

V. Meulen, H. Pohle, S. Poser, 1989, Journal of Neurology.

Low molecular solutes and the blood cerebrospinal fluid barrier

N. Liappis, K. Felgenhauer, M. Nekic, 1982, Klinische Wochenschrift.

Characterization of the human T cell response against the neuronal protein synapsin in patients with multiple sclerosis

F. Weber, M. Mäder, K. Felgenhauer, 2001, Journal of Neuroimmunology.

99mTc-Hexamethylpropylene amine oxime SPECT and X-ray CT in acute cerebral ischaemia

D. Dressler, E. Voth, K. Felgenhauer, 1990, Journal of Neurology.

Immunocytochemical analysis of immunoglobulin-containing cells in CSF and blood in inflammatory disorders of the central nervous system

P. Rieckmann, K. Felgenhauer, T. Weber, 1988, Journal of the Neurological Sciences.

Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count

F. Weber, H. Tumani, W. Beuche, 2000, Journal of Neuroimmunology.

HTLV-I associated myelopathy in patients from Brazil and Iran: neurological manifestations and cerebrospinal fluid findings.

K. Felgenhauer, M. Puccioni-Sohler, B. Kitze, 1995, Arquivos de neuro-psiquiatria.

Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis

W. Tourtellotte, H. Tumani, J. Peter, 1998, Journal of the Neurological Sciences.

The value of CSF analysis for the differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis.

H. Reiber, K. Felgenhauer, P. Lange, 1995, Arquivos de neuro-psiquiatria.

Meningeal carcinomatosis: origin of local IgG production in the CSF.

K. Felgenhauer, A. Bardosi, H. Schipper, 1988 .

[Blood-cerebrospinal fluid barrier and the local immune response in the course of meningitis in childhood].

K. Felgenhauer, D. Wenzel, A. Statz, 1979, Neuropadiatrie.

A soluble form of tumour necrosis factor receptor in cerebrospinal fluid and serum of HTLV-I-associated myelopathy and other neurological diseases

P. Rieckmann, K. Felgenhauer, P. Lange, 1995, Journal of Neurology.

The prevalence of locally-synthesized virus antibodies in various forms of multiple sclerosis

H. Karbe, K. Felgenhauer, H. Schädlich, 1987, Journal of the Neurological Sciences.

Determination of synapsin I and synaptophysin in body fluids by two-site enzyme-linked immunosorbent assays.

A. Wetter, M. Mäder, K. Felgenhauer, 1998, Journal of immunological methods.

Demonstration of zoster virus antibodies in cerebrospinal fluid cells

R. S. Thomas, W. Beuche, K. Felgenhauer, 2004, Journal of Neurology.

Chronic HIV encephalitis — II. clinical aspects

S. Poser, H. Pohle, W. Lüer, 1988, Klinische Wochenschrift.

Evidence for different immune responses to HIV in CSF and serum?

K. Felgenhauer, T. Weber, W. Büttner, 1987, Klinische Wochenschrift.

Purification and N-terminal sequence of β-trace, a protein abundant in human cerebrospinal fluid

B. Schmidt, M. Mäder, K. Felgenhauer, 1993, Neuroscience Letters.

Development of an ultrasensitive enzyme immunoassay for the determination of matrix metalloproteinase-9 (MMP-9) levels in normal human cerebrospinal fluid

F. Weber, R. Hardeland, W. Beuche, 2001, Journal of Neuroimmunology.

The use of recombinant antigens in ELISA procedures for the quantification of intrathecally produced HIV-1-specific antibodies.

S. Poser, J. Haas, W. Lüer, 1991, Journal of immunological methods.

On the removal of nervous proteins from materials used for gelatin manufacturing during processing

R. Poethke, M. Mäder, K. Felgenhauer, 1996 .

Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group.

W. Tourtellotte, J. Peter, K. Felgenhauer, 1998, Journal of the neurological sciences.